# Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC

> **NCT04611165** · PHASE2 · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 50 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT04611165
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-15
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-12-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04611165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04611165, "Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT04611165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*